News
BMRA
2.140
+4.39%
0.090
Weekly Report: what happened at BMRA last week (0928-1002)?
Weekly Report · 1d ago
Weekly Report: what happened at BMRA last week (0921-0925)?
Weekly Report · 09/28 09:07
Biomerica Files $250M Shelf Registration Statement For Mixed Securities Offering
Benzinga · 09/25 19:01
Biomerica files $250M mixed securities shelf
TipRanks · 09/25 19:00
Biomerica files to sell 1.4M shares of common stock for holders
TipRanks · 09/24 21:05
Biomerica Files Prospectus Covering Resale Of Up To 1,403,705 Shares Of Common Stock By Selling Stockholders
Benzinga · 09/24 21:04
Weekly Report: what happened at BMRA last week (0914-0918)?
Weekly Report · 09/21 09:07
Weekly Report: what happened at BMRA last week (0907-0911)?
Weekly Report · 09/14 09:07
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 09/10 12:06
Weekly Report: what happened at BMRA last week (0831-0904)?
Weekly Report · 09/07 09:07
Biomerica Posts Narrower Q4 Loss On Higher Sales; Stock Down
NASDAQ · 09/02 09:32
Biomerica GAAP EPS of -$1.30, revenue of $4.5M
Seeking Alpha · 09/01 12:30
Biomerica Q4 EPS $(0.38) Up From $(0.69) YoY, Sales $875.000K Up From $749.000K YoY
Benzinga · 09/01 12:27
*Biomerica 4Q Sales $875,000 >BMRA
Dow Jones · 09/01 12:21
*Biomerica 4Q Loss $1.1M >BMRA
Dow Jones · 09/01 12:21
Press Release: Biomerica Reports Fiscal 2026 Year-End Financial Results
Dow Jones · 09/01 12:19
Press Release: Biomerica Reports Fiscal 2026 -2-
Dow Jones · 09/01 12:19
Weekly Report: what happened at BMRA last week (0824-0828)?
Weekly Report · 08/31 09:07
Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
Benzinga · 08/28 19:27
Biomerica Insiders Make Bold Move With Fresh Stock Purchases
TipRanks · 08/28 02:03
More
Webull provides a variety of real-time BMRA stock news. You can receive the latest news about Biomerica Inc through multiple platforms. This information may help you make smarter investment decisions.
About BMRA
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients in the diagnosis of various diseases, food intolerances, and other medical complications. The Company’s diagnostic test kits can also be used to measure or detect the presence and levels of specific bacteria, hormones, antibodies, antigens and other substances, which may exist in the human body in small concentrations. Its range of medical diagnostic products is sold in two markets: clinical laboratories and point-of-care settings. The Company’s diagnostic-guided therapy (DGT) product is developed on the inFoods technology platform, which is designed to aid in the management of gastrointestinal conditions such as irritable bowel syndrome (IBS) and other inflammatory diseases.